Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bavarian Nordic
Fierce Pharma
Bavarian Nordic's $160M PRV price reflects new realities
The value of PRVs appears to be on the rise as concerns mount over declining supplies following the sunset of the rare pediatric disease PRV program.
Angus Liu
Jun 18, 2025 11:47am
Bavarian Nordic to shut down San Diego R&D site, lay off 48
Dec 11, 2024 4:49pm
Moderna mpox vaccine passes muster in monkeys
Sep 4, 2024 11:00am
Bavarian Nordic halts cancer vaccine program
Feb 21, 2024 7:25am
BioNTech pockets $90M from CEPI to partner on mpox vaccine
Sep 18, 2023 10:30am
Variant vulnerability vanquishes Bavarian Nordic's COVID vaccine
Sep 1, 2023 5:39am
